PHRX (Pharmagen) ROE % Adjusted to Book Value: 0.00% (As of Mar. 2014)


What is Pharmagen ROE % Adjusted to Book Value?

Pharmagen PHRX -90.00% ROE % Adjusted to Book Value is 0.00% as of Mar. 2014.

Pharmagen's ROE % for the quarter that ended in Mar. 2014 was 0.00%. Pharmagen's PB Ratio for the quarter that ended in Mar. 2014 was N/A. Pharmagen's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2014 was N/A.

Pharmagen ROE % Adjusted to Book Value Related Terms

Pharmagen ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Pharmagen's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagen ROE % Adjusted to Book Value Chart

Pharmagen Annual Data
Trend Jun10 Jun11 Dec12 Dec13
ROE % Adjusted to Book Value
0.00 0.00 0.00 0.00

Pharmagen Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PHRX vs FZMD, SNYR, SGMFF: ROE % Adjusted to Book Value Comparison

For the Medical Distribution subindustry, Pharmagen's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmagen ROE % Adjusted to Book Value vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Pharmagen's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Pharmagen's ROE % Adjusted to Book Value falls into.


Pharmagen ROE % Adjusted to Book Value Calculation

Pharmagen's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2013 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Pharmagen's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2014 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Pharmagen (PHRX) has a ROE % Adjusted to Book Value of 0.00% as of Mar. 2014. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Pharmagen and its competitors.
Is Pharmagen's ROE % Adjusted to Book Value too high?
Pharmagen's current ROE % Adjusted to Book Value is 0.00%.
How does Pharmagen's ROE % Adjusted to Book Value compare to FZMD and SNYR?
Pharmagen's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Distribution company?
A good ROE % Adjusted to Book Value depends on the Medical Distribution industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Pharmagen and its competitors. Pharmagen's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagen stock overvalued right now?
Pharmagen (PHRX) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Pharmagen (PHRX), the current ROE % Adjusted to Book Value is 0.00% as of Mar. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagen Business Description

Address 9337 Fraser Avenue, Silver Spring, MD, USA, 20910
Pharmagen Inc as a distributor of specialty drugs, compounding and admix pharmacy, and producer of over-the-counter branded multivitamins to the healthcare provider market. The company distributes hard-to-find and specialty drugs to the healthcare provider market throughout the United States, while functioning as an aggregator of real-time market demand for these products.